Comparison of RNA-seq and microarray-based models for clinical endpoint predictionWenqian Zhang, Carolina Rosswog, Ying Yu et al.|Genome Biology|2015Cited by 429
Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Clinical Cancer Research|2014Cited by 99
The MAQC-II Project: A comprehensive study of common practices for the development and validation of microarray-based predictive models.Leming Shi, Rafael A. Irizarry, Lajos Pusztai et al.|Unknown|2010Cited by 41
Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0